HAEMONETICS CORP 4
4 · HAEMONETICS CORP · Filed Jan 4, 2008
Insider Transaction Report
Form 4
Popovsky Mark A
VP, Corporate Medical Director
Transactions
- Sale
Common Stock
2008-01-02$61.98/sh−5,000$309,900→ 4,645 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2008-01-02$61.98/sh−5,000$309,900→ 5,000 totalExercise: $26.11From: 2005-05-05Exp: 2014-05-05→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2008-01-02$31.66/sh+5,000$158,300→ 9,645 total
Holdings
- 11,230
Non-Qualified Stock Option (right to buy)
Exercise: $33.15From: 2002-04-30Exp: 2011-04-30→ Common Stock (11,230 underlying) - 13,451
Non-Qualified Stock Option (right to buy)
Exercise: $51.07From: 2008-10-24Exp: 2014-10-24→ Common Stock (13,451 underlying) - 17,000
Non-Qualified Stock Option (right to buy)
Exercise: $41.15From: 2006-07-27Exp: 2015-07-27→ Common Stock (17,000 underlying) - 14,891
Non-Qualified Stock Option (right to buy)
Exercise: $52.76From: 2007-05-05Exp: 2013-05-05→ Common Stock (14,891 underlying)
Footnotes (2)
- [F1]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.